NCT05569681Completed
Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients
Comparison of Two Different Regimens of Bemiparin as a Thromboprophylaxis After Surgery in Morbidly Obese Patients: A Randomized, Outcome-assessor Blinded Trial.
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
Morbid obesity, is known to be associated with a high risk of VTE and, unfortunately, fixed doses of anticoagulant regimens may not provide optimal VTE prophylaxis in these patients especially after surgery.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1248 (actual)
- First submitted
- 3 Oct 2022
- Start date
- 7 Jan 2023
- Primary completion date
- 20 Oct 2026
- Lead sponsor
- Hawler Medical University
- Diseases
- Obesity
- NCT number
- NCT05569681
What you commit to
- Study type: Interventional
- Participants enrolled: 1248
- From 7 Jan 2023 to the primary completion date, 20 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- On oral or parenteral anticoagulants within 5 days before surgery
- Receiving prohibited medications
Other illness
- Known hypersensitivity to unfractionated or LMWHs
- Severe arterial hypertension
Lab values
- Having any contraindication to LMWH, such as active bleeding, history of heparin-induced thrombocytopenia , baseline platelet count \<75 × 108/μl, severe renal disease (glomerular filtration rate \<30 ml/minute), severe liver disease, or uncontrolled hypertension (\>200/120 mmHg)
Other
- Unable to comply with the study treatment and/or follow-up
- Pregnancy or lactation mother
Who the study is looking for
- Participants required surgical intervention in: general surgery, gynecology, bariatric surgery
- Moderate, high, and very high risk for venous thromboembolism according to Caprin RAM
- Participant is willing and able to give informed consent for participation in the study.
- BMI ≥40kg/m2
Age in the registry: 18 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hawler Medical University Coordinator of this site? Confirm its status | Erbil | Iraq | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.